Target intelligence / Profile preview

Cell-surface extracellular matrix receptor (ECM receptor)

Target
ECM receptor
Molecular classification
Receptor, Adhesion molecule, Integrin family, Proteoglycan, Discoidin domain receptor family
01

Overview

Cell-surface extracellular matrix (ECM) receptors are a diverse group of transmembrane proteins that mediate the attachment of cells to the surrounding extracellular environment and translate mechanical and chemical cues into intracellular signals. The most prominent members of this group are the integrins, but it also includes non-integrin receptors such as syndecans, discoidin domain receptors (DDRs), and CD44. These receptors play critical roles in maintaining tissue architecture, regulating cell survival, and directing migration during development and wound healing. In pathological states, dysregulation of ECM receptors is a hallmark of cancer progression, where they facilitate tumor cell invasion and metastasis, as well as fibrotic diseases characterized by excessive matrix deposition. Therapeutic strategies targeting these receptors often involve monoclonal antibodies or small molecules designed to block ligand binding or inhibit downstream signaling cascades.

Other names
Extracellular matrix receptorsECM-binding receptorsCell-matrix adhesion receptors
02

Mechanism of action

Antagonism of ligand binding (e.g., blocking fibrinogen or VCAM-1 binding), modulation of intracellular signaling pathways (outside-in signaling), and inhibition of cell-matrix adhesion.

03

Biological functions

Cell adhesionSignal transductionCell migrationExtracellular matrix organizationCell proliferationCell differentiationApoptosis regulation
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseMetastasis
05

Safety considerations

Bleeding risk (for anti-platelet integrin inhibitors)Increased risk of infection (for leukocyte integrin inhibitors)Progressive multifocal leukoencephalopathy (PML)Impaired wound healing
06

Interacting drugs

Abciximab

5 more in the full profile.

07

Biomarkers

Integrin alpha-V beta-3 expressionCD44 expression levelsSoluble VCAM-1DDR1/2 phosphorylation status

Beyond the preview

Go deeper on Cell-surface extracellular matrix receptor (ECM receptor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface extracellular matrix receptor (ECM receptor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call